Timing of development of osteoradionecrosis post head and neck radiotherapy: does a safe time interval exist for dental extraction?

. 2024 Oct ; 200 (10) : 882-894. [epub] 20240625

Jazyk angličtina Země Německo Médium print-electronic

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid38918259
Odkazy

PubMed 38918259
DOI 10.1007/s00066-024-02251-5
PII: 10.1007/s00066-024-02251-5
Knihovny.cz E-zdroje

INTRODUCTION: Risk factors for developing osteoradionecrosis (ORN) are well known, but less is known about factors influencing the interval between radiotherapy and the onset of ORN. Also, it is unknown whether there is any specific period post-radiotherapy with a reduced probability of ORN when irradiated teeth require extraction. PURPOSE: The primary aim of this study was to identify factors influencing the interval in developing ORN in the following subgroups of patients: (1) patients who spontaneously developed ORN, (2) surgical-intervention-related ORN with a particular focus on patients after mandibulectomy. The secondary aim was to attempt to identify a possible time for safer dental intervention after primary treatment. MATERIALS AND METHODS: The authors retrospectively analysed 1608 head and neck cancer (HNC) patients treated in a single centre. Time intervals were measured from the end of radiotherapy to the development of ORN and further analysed in the subgroups listed above. RESULTS: In all, 141 patients (8.8%) developed intra-oral ORN. Median time from radiotherapy to ORN development in the whole cohort was 9 months. Median interval for spontaneous ORN was 8 months, 6.5 months for intervention-related ORN, and 15 months for patients post-mandibulectomy. In patients who required dental extraction preradiotherapy, median interval of ORN onset was 5 months. CONCLUSION: In our study, a slightly higher proportion of patients with intervention developed ORN earlier in comparison with spontaneous ORN. The period from 12-18 months after radiotherapy was identified as having the highest probability of developing ORN in patients after mandibulectomy. A time for safer dental intervention after primary treatment was not identified.

Zobrazit více v PubMed

Baxi SS, Pinheiro LC, Pati SM, Pfister DG, Oeffinger KC, Elkin EB (2014) Causes of death in long term survivors of head and neck cancer. Cancer 120:1507–1513 PubMed DOI

Tsai CJ, Hofstede TM, Sturgis EM, Garden AS, Lindberg ME, Wei Q, Tucker SL, Dong L (2013) Osteoradionecrosis and radiation dose to the mandible in patients with oropharyngeal cancer. Int J Radiat Oncol Biol Phys 85(2):415–420 PubMed DOI

Aarup-Kristensen S, Hansen CR, Fornber L, Brink C, Eriksen JG, Johansen J Osteoradionecrosis of the mandible after radiotherapy for head and neck cancer: risk factors and dose-volume correlations. Acta Oncol. https://doi.org/10.1080/0284186X.2019.1643037

Caparrotti F, Huang SH, Lu L, Bratman SV, Ringash J, Bayley A, Cho J, Giuliani M, Kim J, Waldron J, Hansen A, Tong L, Xu W, O’Sullivan B, Wood R, Goldstein D, Hope A (2017) Osteoradionecrosis of the mandible in patients with oropharyngeal carcinoma treated with intensity-modulated radiotherapy. Cancer 123(19):3691–3700. https://doi.org/10.1002/cncr.30803 PubMed DOI

Kovarik JP, Voborna I, Barclay S, Iqbal MS, Cunnell M, Kelly C, Willis N, Kennedy M, Kovarik J (2022) Osteoradionecrosis after treatment of head and neck cancer: a comprehensive analysis of risk factors with a particular focus on role of dental extractions. Br J Oral Maxillofac Surg 60(2):168–173. https://doi.org/10.1016/j.bjoms.2021.03.009 PubMed DOI

Notani K, Yamazaki Y, Kitada H, Sakakibara N, Fukuda H, Omori K, Nakamura M (2003) Management of mandibular osteoradionecrosis corresponding to the severity of osteoradionecrosis and the method of radiotherapy. Head Neck 25(3):181–186. https://doi.org/10.1002/hed.10171 PubMed DOI

Kubota H, Miyawaki D, Mukumoto N et al (2021) Risk factors for osteoradionecrosis of the jaw in patients with head and neck squamous cell carcinoma. Radiat Oncol. https://doi.org/10.1186/s13014-020-01701-5 PubMed DOI PMC

Owosho AA, Tsai CJ, Lee RS, Freymiller H, Kadempour A, Varthis S et al (2017) The prevalence and risk factors associated with osteoradionecrosis of the jaw in oral and oropharyngeal cancer patients treated ith intensity-modulated radiation therapy: the memorial Sloan Kettering cancer center experience. Oral Oncol 64:44–51. https://doi.org/10.1016/j.oraloncology.2016.11.015 PubMed DOI

Reuther T, Schuster T, Mende U, Kübler A (2003) Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour patients—a report of a thirty year retrospective review. Int J Oral Maxillofac Surg 32(3):289–295. https://doi.org/10.1054/ijom.2002.0332 PubMed DOI

Moon DH, Moon SH, Wang K, Weissler MC, Hackman TG, Zanation AM et al (2017) Incidence of, and risk factors for, mandibular osteoradionecrosis in patients with oral cavity and oropharynx cancers. Oral Oncol 72:98–103. https://doi.org/10.1016/j.oraloncology.2017.07.014 PubMed DOI

Kabir R, Durand R, Roberge D, Dufresne E, Nguyen-Tân PF (2022) Incidence of osteoradionecrosis of the jaws: a retrospective study of 620 patients with head and neck cancer. Gen Dent 70(4):72–77 PubMed

Kuhnt T, Stang A, Wienke A, Vordermark D, Schweyen R, Hey J (2016) Potential risk factors for jaw osteoradionecrosis after radiotherapy for head and neck cancer. Radiat Oncol 11:101. https://doi.org/10.1186/s13014-016-0679-6 PubMed DOI PMC

Chang DT, Sandow PR, Morris CG, Hollander R, Scarborough L, Amdur RJ, Mendenhall WM (2007) Do pre-irradiation dental extractions reduce the risk of osteoradionecrosis of the mandible? Head Neck 29(6):528–536. https://doi.org/10.1002/hed.20538 PubMed DOI

van Dijk LV, Abusaif AA, Rigert J, Naser MA, Hutcheson KA, Lai SY, Fuller CD, Mohamed ASR, MD Anderson Symptom Working Group. (2021) Normal tissue complication probability (NTCP) prediction model for osteoradionecrosis of the mandible in patients with head and neck cancer after radiation therapy: large-scale observational cohort. Int J Radiat Oncol Biol Phys 111(2):549–558. https://doi.org/10.1016/j.ijrobp.2021.04.042 PubMed DOI PMC

Möring MM, Mast H, Wolvius EB, Verduijn GM, Petit SF, Sijtsema ND, Jonker BP, Nout RA, Heemsbergen WD (2022) Osteoradionecrosis after postoperative radiotherapy for oral cavity cancer: a retrospective cohort study. Oral Oncol 133:106056. https://doi.org/10.1016/j.oraloncology.2022.106056 PubMed DOI

Lee CT, Litwin S, Yao CMKL, Liu JC, Ridge JA, Galloway TJ (2022) Osteoradionecrosis rate in oropharynx cancer treated with dose volume histogram based constraints. Radiother Oncol 176:215–221. https://doi.org/10.1016/j.radonc.2022.10.011 PubMed DOI

Studer G, Bredell M, Studer S, Huber G, Glanzmann C (2016) Risk profile for osteoradionecrosis of the mandible in the IMRT era. Strahlenther Onkol 192(1):32–39. https://doi.org/10.1007/s00066-015-0875-6 PubMed DOI

Kovarik JP, Voborna I, Barclay S, Nicol A, Kelly C, Kovarik PD, Iqbal MS, Kovarik J (2021) Dental loss after radiotherapy for head and neck cancer. Br Dent J 231(8):473–478. https://doi.org/10.1038/s41415-021-3536-4 PubMed DOI

Vigarios E, Epstein JB, Sibaud V (2017) Oral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors. Support Care Cancer 25:1713–1739 PubMed DOI

Beumer J III, Harrison R, Sanders B, Kurrasch M (1983) Postradiation dental extractions: a review of the literature and a report of 72 episodes. Head Neck 6:581–586. https://doi.org/10.1002/hed.2890060107 DOI

Thorn JJ, Hansen HS, Specht L, Bastholt L (2000) Osteoradionecrosis of the jaws: clinical characteristics and relation to the field of irradiation. J Oral Maxillofac Surg 58(10):1088–1093. https://doi.org/10.1053/joms.2000.9562 (discussion 1093–5) PubMed DOI

Marx RE (1983) Osteoradionecrosis: a new concept of its pathophysiology. J Oral Maxillofac Surg 41(5):283–288. https://doi.org/10.1016/0278-2391(83)90294-x PubMed DOI

Kovarik PDE, Patil R, Cvek J, Kelly C, Jackson M, Mackenzie L, West N, Willis N, Kovarik JP, Banks R, Kennedy M, Adams J, Iqbal MS (2023) Extra-mandibular osteoradionecrosis after the treatment of head and neck cancer. Clin Oncol 35(9):e498–e505. https://doi.org/10.1016/j.clon.2023.06.013 DOI

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...